Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1251-1257
Published online before print September 11, 2006, doi: 10.1161/CIRCULATIONAHA.105.570838
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/12/1251    most recent
CIRCULATIONAHA.105.570838v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stroupe, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stroupe, K. T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Bypass Surgery
*Coronary Artery Disease
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease
Right arrowRelated Article

(Circulation. 2006;114:1251-1257.)
© 2006 American Heart Association, Inc.


Health Services and Outcomes Research

Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients

Kevin T. Stroupe, PhD; Douglass A. Morrison, MD, PhD; Mark A. Hlatky, MD; Paul G. Barnett, PhD; Lishan Cao, MS; Christopher Lyttle, MA; Denise M. Hynes, RN, PhD; William G. Henderson, PhD, for the Investigators of Veterans Affairs Cooperative Studies Program #385 (AWESOME: Angina With Extremely Serious Operative Mortality Evaluation)

From the Cooperative Studies Program Coordinating Center (K.T.S.), Hines VA Hospital, Hines, Ill; Midwest Center for Health Services and Policy Research (K.T.S., D.M.H.), Hines VA Hospital, Hines, Ill; Feinberg School of Medicine (K.T.S., L.C., C.L.), Chicago, Ill; VA Information Resource Center (K.T.S., D.M.H.), Hines, Ill; Tucson VA Medical Center (D.A.M.), Tucson, Ariz; University of Arizona (D.A.M.), Tucson, Ariz; Stanford University School of Medicine (M.A.H., P.G.B.), Stanford, Calif; VA Health Economics Resource Center (P.G.B.), Menlo Park, Calif; VA Cooperative Studies Program Coordinating Center (P.G.B.), Palo Alto, Calif; Loyola University Chicago (D.M.H.), Maywood, Ill; and University of Colorado Health Outcomes Program (W.G.H.), Aurora, Col.

Correspondence to Kevin T. Stroupe, PhD, Edward Hines, Jr, VA Hospital, PO Box 5000 (151H), Hines, IL 60141. E-mail Kevin.Stroupe{at}va.gov

Received June 22, 2005; revision received June 23, 2006; accepted June 27, 2006.

Background— A Department of Veterans Affairs Cooperative Study randomized high-risk patients with medically refractory myocardial ischemia, a group largely excluded from previous trials, to urgent revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The present study examined the cost-effectiveness of PCI versus CABG for these high-risk patients.

Methods and Results— Of 454 patients at 16 Department of Veterans Affairs medical centers, 445 were available for the economic analysis (218 PCI and 227 CABG patients). Total costs were assessed at 3 and 5 years from the third-party payer’s perspective, and effectiveness was measured by survival. After 3 years, average total costs were $63 896 for PCI versus $84 364 for CABG patients, a difference of $20 468 (95% confidence interval [CI] $13 918 to $27 569). CIs were estimated by bootstrapping. Survival at 3 years was 0.82 for PCI versus 0.79 for CABG patients (P=0.34). Precision of the cost-effectiveness estimates were assessed by bootstrapping. PCI was less costly and more effective at 3 years in 92.6% of the bootstrap replications. After 5 years, average total costs were $81 790 for PCI versus $100 522 for CABG patients, a difference of $18 732 (95% CI $9873 to $27 831), whereas survival at 5 years was 0.75 for PCI patients versus 0.70 for CABG patients (P=0.21). At 5 years, PCI remained less costly and more effective in 89.4% of the bootstrap replications.

Conclusions— PCI was less costly and at least as effective for the urgent revascularization of medically refractory, high-risk patients over 5 years.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 114: 1225. [Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. P. Brown, A. D. Kugelmass, D. J. Cohen, M. R. Reynolds, S. D. Culler, A. D. Dee, and A. W. Simon
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States medicare program.
Ann. Thorac. Surg., June 1, 2008; 85(6): 1980 - 1986.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Ann Intern Med, November 20, 2007; 147(10): 703 - 716.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. L. Bair, J. B. Muhlestein, H. T. May, K. G. Meredith, B. D. Horne, R. R. Pearson, Q. Li, K. R. Jensen, J. L. Anderson, and D. L. Lappe
Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry
Circulation, September 11, 2007; 116(11_suppl): I-226 - I-231.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. L. Frye
Update in Cardiology
Ann Intern Med, August 7, 2007; 147(3): 180 - 186.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Radford
Percutaneous Coronary Intervention "Dominates" Coronary Artery Bypass Graft Surgery for High-Risk Patients: Good News for Patients, a Challenge for Healthcare Planners
Circulation, September 19, 2006; 114(12): 1229 - 1231.
[Full Text] [PDF]